[Is the rebound effect in liver diseases following glucocorticoid therapy avoidable by using alpha-lipoic acid?].
D002908:Chronic Disease; D004347:Drug Interactions; D006801:Humans; D008107:Liver Diseases / Q000188:drug therapy*; D010248:Paramethasone / Q000627:therapeutic use; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*; D008063:Thioctic Acid / Q000627:therapeutic use*
D008063:Thioctic Acid; D010248:Paramethasone
Ist der Rebound-Effekt bei Leberkrankheiten nach Glukokortikoidbehandlung durch Alpha-Liponsäure vermeidbar.